US Stem Cell Inc (USRM)

[Dragon Lady]

If the majority of any of the things you mentioned had already actually "happened" - you'd have already seen them in an official PR. Companies can not "sit" on key, material event "news" such as financing relationships, key deals, etc. So no, I don't expect anything new other than more dilution, very little cash on the balance sheet entry, a near word for word copy of past 10-Q/10-K docs which has been the norm for about 2 yrs now, etc. Nothing "new" expected IMO. I'll look for a) the share count page 1 then b) read the balance sheet with the cash line, line one being the first thing I look at. Then, I'll go down to the details in the "financing" section and do a search for the words "note" and "convertible", etc. I'll look for the "Mirror" section, and if it's as last report- it barely got a passing mention and had no updated info. I don't expect much difference now- if they had key enrollment metrics, they would have already released them. I'll then search for all the other PR "deals" released over the past 6 months or so, and if it's SOP, I don't even expect to find them mentioned or very little to be said about them. That's about it in a nut shell.